View drug registration information details.
| Items | Registration information |
|---|
| ID | 220 |
|---|
| No | 220 |
|---|
| Brand Name | CABODX 20 MG |
|---|
| Ingredients | CABOZANTINIB 20 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30 C |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 90'S/BOTTLE |
|---|
| Dispensing Category | PRESCRIPTION |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | TREATMENT OF MEDULLARY THYROID CANCER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | GREY CAPSULE |
|---|
| Note | |
|---|
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 09 L 1013/23 |
|---|
| FDD Registration Date | 2023-09-20 |
|---|
| Expiry Date | 2026-09-19 |
|---|
Back to drug list
|
